Human medicines European public assessment report (EPAR): Truqap, capivasertib, Date of authorisation: 17/06/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Truqap, capivasertib, Date of authorisation: 17/06/2024, Revision: 1, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Equilis Prequenza, vaccine against equine influenza in horses, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Equilis Prequenza, vaccine against equine influenza in horses, Status: Authorised

Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Equilis Prequenza Te, vaccine against equine influenza and tetanus in horses, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Equilis Prequenza Te, vaccine against equine influenza and tetanus in horses, Status: Authorised

Clinical Trials Information System (CTIS) bitesize talk: Change of sponsor in CTIS, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 March 2025, 15:30 (CET) to 5 March 2025, 17:00 (CET)

Clinical Trials Information System (CTIS) bitesize talk: Change of sponsor in CTIS, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 March 2025, 15:30 (CET) to 5 March 2025, 17:00 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness